Tourjman Smadar Valérie, M. D.

Research axix

• Treatment and Rehabilitation adapted to Populations

University affiliation

• Adjunct clinical professor, Department of Psychiatry, l’Université de Montréal
• Associate Director of clinical research, Research Fernand-Seguin Center

Profile

A psychiatrist and researcher, Dr Tourjman interests center around the development and refinement of treatment for mood disorders, including resistant depression. A parallel interest is adult attention deficit disorder. She has published in these areas. Her current projects include research into the role of inflammatory markers in depression, treatment concordance in depression and adult attention deficit disorder, and treatment of ADHD.

Awards and Honours

Fellowship (1989-90), Canadian Psychiatric Research Foundation- A study of genetic markers in hereditary acromelalgia

Current Projects

• Inflammatory markers and cognition in major depression
• Inflammatory markers and cerebral imagery in major depression
• The relationship of subjective perception of cognitive deficits and treatment concordance
• The treatment of adult ADHD with a non-stimulant
• The effect of novel treatments in bipolar depression
  

Recents Publications

Tourjman S.V., Le psychiatre et la prescription piégée : entre les données de la recherche et la réalité. Éthique Publique, vol 8, n° 2, 2006 : 27-33.

Dorée.J.P., Des Rosiers J., Lew V., Gendron A., Elie R., Stip E., Tourjman S.V. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium. Current Medical Research Opinions 2007 Feb;23(2):333-41.

Tourjman S.V. Médicaments et espaces de communication : Psychiatrie, traitement et Internet. Revue Internationale sur le Médicament.

Tourjman S.V., Bilodeau M : Improvement with Duloxetine in an Adult ADHD Patient. J Atten Disord. April 9, 2009.